High Fas expression in gastric carcinoma cells as a factor correlating with the occurrence of metastases to regional lymph nodes

Advances in Medical Sciences

Volumn 59, Issue 1, 2014, Pages 47-51

  Gryko, Mariusz ^a   Guzińska Ustymowicz, Katarzyna ^a   Kis̈luk, Joanna ^a   Cepowicz, Dariusz ^a   Kemona, Andrzej ^a   Kędra, Bogusław ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Fas; Fas L; Gastric cancer

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH WALL; CANCER GRADING; CANCER STAGING; ENZYME IMMUNOASSAY; FOLLOW UP; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

ANTIGENS, CD95; FAS LIGAND PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907652095     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2013.07.005     Document Type: Article

References (42)

1. G. Bjelakovic, A. Nagorni, M. Bjelakovic, I. Stamenkovic, R. Arsic, and V. Katić Apoptosis: programmed cell death and its clinical implications Med Biol 12 1 2005 6 11
2. A. Houston, and J. O'Connell The Fas signalling pathway and its role in the pathogenesis of cancer Curr Opin Pharmacol 4 August (4) 2004 321 326
3. H.O. Lee, and T.A. Ferguson Biology of FasL Cytokine Growth Factor Rev 14 June-August (3/4) 2003 325 335
4. F. Mollinedo, and C. Gajate Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy Drug Resist Updat 9 February-April (1/2) 2006 51 73
5. M. Osaki, S. Kase, I. Kodani, M. Watanabe, H. Adachi, and H. Ito Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma BMC Cancer 10 2010 275
6. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC Cancer Staging Handbook. From the AJCC Cancer Staging Manual 7th ed. 2010 Springer New York-Dordrecht-Heidelberg-London
7. C.R. Mehta, and N.R. Patel Algorithm 643: FEXACT: A FORTRAN subroutine for Fisher's exact test on unordered r × c contingency tables ACM Trans Math Softw 12 1986 154 161
8. W. Wang, Y.F. Li, X.W. Sun, Y.B. Chen, W. Li, and D.Z. Xu Prognosis of 980 patients with gastric cancer after surgical resection Chin J Cancer 29 November (11) 2010 923 930
9. M. Zhang, Z. Li, B. Zhao, Y. Wei, G. Zhu, and Y. Ma Predictors of long-term survival in large gastric carcinoma patients Hepatogastroenterology 58 November-December (112) 2011 2162 2165
10. Y. Liu, X.H. Chen, X.H. Meng, C.F. Liu, L.L. Zhao, and J.W. Han Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator? Hepatogastroenterology 59 March-April (114) 2012 623 626
11. N. Shiraishi, K. Sato, K. Yasuda, M. Inomata, and S. Kitano Multivariate prognostic study on large gastric cancer J Surg Oncol 96 July (1) 2007 14 18
12. O. Asoglu, H. Karanlik, M. Parlak, M. Kecer, M. Muslumanoglu, and A. Igci Metastatic lymph node ratio is an independent prognostic factor in gastric cancer Hepatogastroenterology 56 May-June (91/92) 2009 908 913
13. F.J. Hsieh, Y.C. Wang, J.T. Hsu, K.H. Liu, and C.N. Yeh Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger J Surg Oncol 105 March (3) 2012 304 309
14. K. Liu Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer World J Gastrointest Oncol 2 November (11) 2010 399 406
15. W. Zhang, E.X. Ding, Q. Wang, D.Q. Zhu, J. He, and Y.L. Li Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege World J Gastroenterol 11 June (23) 2005 3632 3635
16. A.E. Ryan, F. Shanahan, J. O'Connell, and A.M. Houston Fas ligand promotes tumor immune evasion of colon cancer in vivo Cell Cycle 5 February (3) 2006 246 249 [Epub 2006, Feb 14]
17. Q. Zhu, J.Y. Liu, H.W. Xu, C.M. Yang, A.Z. Zhang, and Y. Cui Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system World J Gastroenterol 11 October (39) 2005 6125 6129
18. K.F. Yoong, S.C. Afford, S. Randhawa, S.G. Hubscher, and D.H. Adams Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion Am J Pathol 154 March (3) 1999 693 703
19. T. Ohta, A. Elnemr, H. Kitagawa, M. Kayahara, H. Takamura, and T. Fujimura Fas ligand expression in human pancreatic cancer Oncol Rep 12 October (4) 2004 749 754
20. W.V. Bernstorff, J.N. Glickman, R.D. Odze, F.A. Farraye, H.G. Joo, and P.S. Goedegebuure Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape Cancer 94 May (10) 2002 2552 2560
21. W.V. Bernstorff, R.A. Spanjaard, A.K. Chan, D.C. Lockhart, N. Sadanaga, and I. Wood Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand Surgery 125 January (1) 1999 73 84
22. S. Ohno, M. Tachibana, M. Shibakita, D.K. Dhar, H. Yoshimura, and S. Kinugasa Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer Ann Surg Oncol 7 December (10) 2000 750 757
23. H. Nagashima, M. Mori, N. Sadanaga, K. Mashino, Y. Yoshikawa, and K. Sugimachi Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis Int J Oncol 18 June (6) 2001 1157 1162
24. H.C. Zheng, J.M. Sun, Z.L. Wei, X.F. Yang, Y.C. Zhang, and Y. Xin Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer World J Gastroenterol 9 July (7) 2003 1415 1420
25. T.B. Lee, Y.D. Min, S.C. Lim, K.J. Kim, H.J. Jeon, and S.M. Choi Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells J Gastroenterol Hepatol 17 January (1) 2002 32 38
26. X.H. Zhao, S.Z. Gu, H.G. Tian, P. Quan, and B.R. Pan Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue World J Gastroenterol 11 25 2005 3846 3849
27. Q. Li, J. Peng, X.H. Li, T. Liu, Q.C. Liang, and G.Y. Zhang Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues World J Gastroenterol 16 10 2010 1274 1278
28. M.W. Bennett, J. O'connell, G.C. O'sullivan, D. Roche, C. Brady, and J. Kelly Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer Gut 44 2 1999 156 162
29. J.M. Houghton, R. Korah, L.E. Harrisom, K.O. Clarke, and J.J. Michel Fas ligand expression on intestinal type gastric carcinoma but not diffuse type: evidence for immune evasion Am J Gastroenterol 9 2001 57
30. H. Liu, H. Ubukata, T. Tabuchi, T. Nakachi, H. Nagata, and J. Shimazaki The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response Mol Cell Biochem 331 November (1/2) 2009 181 186 [Epub 2009, May 21]
31. M.S. Lim, H.W. Lee, H. Im, B.S. Kim, M.Y. Lee, and J.Y. Jeon Predictable factors for lymph node metastasis in early gastric cancer-analysis of single institutional experience J Gastrointest Surg 15 October (10) 2011 1783 1788 [Epub 2011, Jul 28]
32. L. Shen, Y. Huang, M. Sun, H. Xu, W. Wei, and W. Wu Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China Can J Gastroenterol 23 May (5) 2009 353 356
33. C. Li, S. Kim, J.F. Lai, S.J. Oh, W.J. Hyung, and W.H. Choi Risk factors for lymph node metastasis in undifferentiated early gastric cancer Ann Surg Oncol 15 March (3) 2008 764 769 [Epub 2007, Nov 28]
34. J.H. Lee, I.J. Choi, M.C. Kook, B.H. Nam, Y.W. Kim, and K.W. Ryu Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology Br J Surg 97 May (5) 2010 732 736
35. M.J. Nam, S.J. Oh, C.A. Oh, D.H. Kim, Y.S. Bae, and M.G. Choi Frequency and predictive factors of lymph node metastasis in mucosal cancer J Gastric Cancer 10 December (4) 2010 162 167
36. Y. Tajima, M. Murakami, K. Yamazaki, Y. Masuda, S. Aoki, and M. Kato Risk factors for lymph node metastasis from gastric cancers with submucosal invasion Ann Surg Oncol 17 June (6) 2010 1597 1604 [Epub 2010, Feb 4]
37. T. Kosaka, K. Usami, N. Ueshige, T. Hasegawa, S. Yoshitani, and J. Sugaya Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases Hepatogastroenterology 53 July-August (70) 2006 629 633
38. J. Nasu, T. Nishina, S. Hirasaki, T. Moriwaki, I. Hyodo, and A. Kurita Predictive factors of lymph node metastasis in patients with undifferentiated early gastric cancers J Clin Gastroenterol 40 May-June (5) 2006 412 415
39. N. Abe, T. Watanabe, K. Suzuki, H. Machida, H. Toda, and Y. Nakaya Risk factors predictive of lymph node metastasis in depressed early gastric cancer Am J Surg 183 February (2) 2002 168 172
40. S. Kikuchi, H. Matsuzaki, A. Kurita, N. Kobayashi, H. Shimao, and Y. Sakakibara Tumor volume as an indicator of nodal status in advanced gastric carcinoma In Vivo 15 July-August (4) 2001 295 298
41. S. Kikuchi, S. Sakuramoto, N. Kobayashi, H. Shimao, Y. Sakakibara, and K. Sato Tumor volumetry: proposal of a new concept to predict lymph node metastasis in early gastric cancer Anticancer Res 20 September-October (5C) 2000 3669 3674
42. H. Yamashita, J. Kitayama, and H. Nagawa Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer Jpn J Clin Oncol 35 October (10) 2005 595 600 [Epub 2005, Sep 26]